Question 1

How do I set a price alert for CGEM?

Accepted Answer

To set a CGEM price alert on Stock Alarm Pro, navigate to the CGEM quote page, select "Set Alert," choose your trigger type (price target, % move, RSI level, MACD, or volume breakout), and set your delivery channel. Stock Alarm Pro supports instant push notifications, SMS, and automated phone call alerts.

Question 2

Can I get phone call alerts for CGEM?

Accepted Answer

Yes. Stock Alarm Pro provides real-time automated phone call alerts for CGEM. Phone call alerts ensure you are immediately awakened or interrupted during critical volatility events, overnight earnings moves, or strict stop-loss levels when silent push notifications might be overlooked.

Question 3

What types of alerts can I set for Cullinan Therapeutics Inc?

Accepted Answer

Stock Alarm Pro supports over 125 trigger types for CGEM: price target alerts (above/below target), intraday percentage moves, RSI overbought/oversold levels, 50-day and 200-day moving average crossovers (golden cross / death cross), relative volume (RVOL) spikes, confirmed earnings date releases, and SEC Form-4 insider transaction filings.

Question 4

How quickly will I be notified about CGEM price changes?

Accepted Answer

CGEM alerts are evaluated continuously in real-time against live market telemetry. Notifications are dispatched within sub-second latency via push notifications, SMS, or phone calls as soon as your trigger condition is met across regular, pre-market, and after-hours trading sessions.

Question 5

Is Stock Alarm Pro free to use for CGEM alerts?

Accepted Answer

Yes, Stock Alarm Pro offers a free tier that includes 3 active price alerts for CGEM and other stocks. Full Pro membership is $20/month or $168/year with a 7-day free trial, unlocking unlimited alerts, phone call delivery, SMS, all 125+ technical indicators, institutional screeners, and real-time market telemetry across web, iOS, and Android.

	Reported			Consensus estimates
Fiscal period	FY2023Dec '23	FY2024Dec '24	FY2025Dec '25	FY2026Dec '26	FY2027Dec '27	FY2028Dec '28	FY2029Dec '29	FY2030Dec '30
Revenue (M)	–	1.7	5.2	3.9	71.1	74.4	107.5	283.5
Growth YoY	–	–	+210.8%	−25.4%	+1741.4%	+4.5%	+44.6%	+163.6%
High estimate	–	3.0	9.3	6.9	159.1	133.5	193.0	508.9
Low estimate	–	0.9	2.6	2.0	17.0	38.0	54.9	144.8
Analysts	–	5	7	7	8	8	6	6
EPS, adjusted	−3.69	−3.03	−3.35	−3.11	−2.21	−2.68	−2.78	−1.36
Growth YoY	−255.7%	n/m	n/m	n/m	n/m	n/m	n/m	n/m
High estimate	–	–	–	−2.80	−1.66	−2.49	−1.01	−0.49
Low estimate	–	–	–	−3.56	−2.64	−2.99	−5.66	−2.76
Analysts	–	–	–	7	8	7	2	4

Firm	Analyst	Rating	Prev rating	Target	Prev target	Chg	Upside	Date
Wedbush	Robert Driscoll	Outperform	Outperform	$37.00	$36.00	+3%	+238%	Nov 11
BTIG	Julian Harrison	Buy	Buy	$41.00	$40.00	+2%	+275%	Oct 28
HC Wainwright & Co.	Robert Burns	Buy	Buy	$35.00	$30.00	+17%	+220%	Oct 2
UBS	David Dai	Buy · May 2025	Buy	$27.00	$30.00	−10%	+147%	Aug 17
Stifel Nicolaus	Alex Thompson	Buy · Feb 2025	Buy	$28.00	–	–	+156%	Mar 10
Guggenheim	–	–	–	$30.00	–	–	+174%	Feb 2
Morgan Stanley	–	Overweight · Aug 2025	Overweight	$30.00	$38.00	−21%	+174%	Jan 8
New Street	–	–	–	$26.00	–	–	+138%	Nov 20, 2025

Explore More

S&P 500 Sector Leaderboards

Fundamental Metric Rankings

Consensus

Price vs analyst targets

Revenue and EPS estimates

Brokers